Citadel Aurobindo Biotech Limited

Pharmaceutical company manufacturing and distributing various types of medicines since 2002.

2002 | Chennai, Tamil Nadu (India) | Active
Last Updated:

Citadel Aurobindo Biotech Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 22 Year, 11 Months
  • Last Filing with ROC 31 Mar 2019
  • Satisfied Charges ₹ 40.00 Cr
  • Revenue Growth -44.42%
  • Profit Growth -9583.74%
  • Ebitda -432.91%
  • Net Worth -0.01%
  • Total Assets -76.73%

About Citadel Aurobindo Biotech

Citadel Aurobindo Biotech Limited (CABL) is a Public Limited Indian Non-Government Company incorporated in India on 22 March 2002 and has a history of 22 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.

The company has closed loans amounting to ₹40.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Mruthyunjaya Kapuluru, Rajiv Krishnamurthy, and Sardar Singh serve as directors at the Company.

Company Details

  • Location

    Chennai, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24231TN2002PLC048652

  • Company No.

    048652

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    22 Mar 2002

  • Date of AGM

    05 Sep 2020

  • Date of Balance Sheet

    31 Mar 2019

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Pharma

Who are the key members and board of directors at Citadel Aurobindo Biotech?

Board Members (3)

NameDesignationAppointment DateStatus
Mruthyunjaya Kapuluru Country flag representing In Director 15-Apr-2002Current
Rajiv Krishnamurthy Country flag representing In Director 06-Feb-2007Current
Sardar Singh Country flag representing In Director 04-Dec-2006Current

Financial Performance of Citadel Aurobindo Biotech.

Citadel Aurobindo Biotech Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 44.42% decrease. The company also saw a substantial fall in profitability, with a 9583.74% decrease in profit. The company's net worth dipped by a decrease of 0.01%.

Citadel Aurobindo Biotech revenue growth over time
Citadel Aurobindo Biotech profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-44.42%
Revenue from Operations
Total Assets
-76.73%
Profit or Loss
-9583.74%
Net Worth
-0.01%
EBITDA
-432.91%

What is the Ownership and Shareholding Structure of Citadel Aurobindo Biotech?

In 2019, Citadel Aurobindo Biotech had a public holding of 100.00%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹40.00 Cr

Charges Breakdown by Lending Institutions

  • Uti Bank Limited : 30.00 Cr
  • Standard Chartered Bank : 10.00 Cr

Latest Charge Details

DateLenderAmountStatus
24 Jan 2003Uti Bank Limited₹30.00 CrSatisfied
21 Oct 2002Standard Chartered Bank₹10.00 CrSatisfied

How Many Employees Work at Citadel Aurobindo Biotech?

Unlock and access historical data on people associated with Citadel Aurobindo Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Citadel Aurobindo Biotech Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Citadel Aurobindo Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citadel Aurobindo Biotech's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Citadel Aurobindo Biotech

Recent activity within the organization

  • Annual General Meeting

    Citadel Aurobindo Biotech Limited last Annual general meeting of members was held on 05 Sep 2020 as per latest MCA records.

  • Balance Sheet

    Citadel Aurobindo Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chennai.

  • Director Appointment

    Rajiv Krishnamurthy was appointed as a Director was appointed as a Director on 06 Feb 2007 & has been associated with this company since 18 years 1 month .

  • Charges

    A charge registered on 24 Jan 2003 via Charge ID 90293101 with Uti Bank Limited was fully satisfied on 11 Dec 2006.

  • Director Appointment

    Sardar Sulakshan Singh was appointed as a Director was appointed as a Director on 04 Dec 2006 & has been associated with this company since 18 years 3 months .

  • Charges

    A charge registered on 21 Oct 2002 via Charge ID 90293065 with Standard Chartered Bank was fully satisfied on 31 Oct 2006.

Frequently asked questions

  • What is the Incorporation or founding date of Citadel Aurobindo Biotech Limited?

    Citadel Aurobindo Biotech Limited was incorporated on 22 Mar 2002.

  • What is authorized share capital and paid-up capital of Citadel Aurobindo Biotech Limited?

    The authorized share capital of Citadel Aurobindo Biotech Limited is ₹ 2.00 Cr and paid-up capital is ₹ 2.00 Cr.

  • Who are the current board members & directors of Citadel Aurobindo Biotech Limited?

    Currently 3 directors are associated with Citadel Aurobindo Biotech Limited.

    • Mruthyunjaya Reddy Kapuluru
    • Rajiv Krishnamurthy
    • Sardar Sulakshan Singh

  • What is the registered address of Citadel Aurobindo Biotech Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Citadel Aurobindo Biotech Limited is 43 Main Road Velacherry Velacherry, India, Chennai - 600 042., Tamil Nadu, 600042.

  • What is the corporate identification number (CIN) and company number of Citadel Aurobindo Biotech Limited?

    The corporate identification number (CIN) of Citadel Aurobindo Biotech Limited is U24231TN2002PLC048652 and the company number is 048652 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Citadel Aurobindo Biotech Limited?

    According to the financial reports for the fiscal year 2019, the revenue trend for Citadel Aurobindo Biotech Limited has fallen by -44.42%.

  • What change has been observed in the net worth of Citadel Aurobindo Biotech Limited, and by what percentage?

    The financial reports for the fiscal year 2019 indicates that The net worth of Citadel Aurobindo Biotech Limited has experienced an downturn of -0.01%.

  • When was the last Balance Sheet of Citadel Aurobindo Biotech Limited filed with the ROC?

    The most recent Balance Sheet for Citadel Aurobindo Biotech Limited was filed with the ROC on 31 Mar 2019.

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors